| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.64 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.52 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.48 | 0.09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.22 | 0.0008 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.22 | 0.0005 |